⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4954752 | 1.00 | — | — | |
| SCHEMBL3688615 | 1.00 | — | — | |
| SCHEMBL8381180 | 1.00 | — | — | |
| SCHEMBL3478911 | 1.00 | — | — | |
| SCHEMBL16051190 | 1.00 | — | — | |
| SCHEMBL1983125 | 1.00 | — | — | |
| SCHEMBL27753942 | 1.00 | — | — | |
| SCHEMBL14326431 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL30177889 | 0.98 | — | — | |
| Hydrochloric Acid SCHEMBL30187341 | 0.98 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2970278-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | AbbVie Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| WO-2014139328-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2014-09-18 | — | — | WO | claimed |
| CN-120129485-A | Methods, compositions, and systems for assessing visual function | 英属开曼群岛商倍亮生物有限公司 | 2025-06-10 | — | — | CN | disclosed |
| CN-119454705-A | Formulations and methods of use of RBP4 inhibitors | 倍亮生物有限责任公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-118574615-A | Tablet formulations of RBP4 inhibitors and methods of use | 倍亮生物有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-117440774-A | Biomarkers of age-related macular degeneration | 倍亮生物有限责任公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-114364382-A | Formulations and methods of use of RBP4 inhibitors | 倍亮生物有限责任公司 | 2022-04-15 | — | — | CN | disclosed |
| EP-3495357-B1 | 4-PHENYLPIPERIDINES, THEIR PREPARATION AND USE | UNIV COLUMBIA (US) | 2021-05-05 | — | — | EP | disclosed |
| EP-2970278-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | AbbVie Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| WO-2014139328-A1 | PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS | ABBVIE INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| EP-0790254-B1 | Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them | ADIR (FR) | 2001-08-22 | — | — | EP | disclosed |
| EP-0684257-B1 | Pseudopeptide derivatives of neurokinines, process for their preparation and pharmaceutical compositions comprising them | ADIR (FR) | 1999-09-22 | — | — | EP | disclosed |
| US-5708016-A | Pseudopeptides derived from neurokinins | ADIR ET COMPAGNIE (FR) | 1998-01-13 | — | — | US | disclosed |
| EP-0790254-A1 | Pseudopeptides derived from neurokinines, process of preparation and pharmaceutical compositions comprising them | ADIR ET COMPAGNIE (FR) | 1997-08-20 | — | — | EP | disclosed |
| US-5561113-A | ANALGESICS; ANTIIFLAMMATORY AGENTS; GASTROINTESTINAL, UROGENITAL AND NERVOUS SYSTEM(CNS) DISORDERS; ASTHMA; ANTIALLERGENS | ADIR ET COMPAGNIE (FR) | 1996-10-01 | — | — | US | disclosed |